Target intelligence / Profile preview

Nucleoside Transporter (NT)

Target
NT
Molecular classification
Transporter, Membrane protein, SLC29 (ENT), SLC28 (CNT), Uniporter, Symporter
01

Overview

Nucleoside transporters are membrane proteins responsible for the transport of nucleosides and nucleobases across cell membranes. They are crucial for nucleotide salvage, cellular metabolism, and the pharmacokinetics of many drugs. Two main classes exist: equilibrative (ENTs) that facilitate passive transport, and concentrative (CNTs) that mediate active, sodium/proton-coupled uptake. They play a key role in the uptake of therapeutic agents including cytotoxic anticancer drugs and antiviral medications, and their altered expression can impact drug efficacy/resistance.

Other names
Equilibrative Nucleoside TransporterENTConcentrative Nucleoside TransporterCNTSLC29 familySLC28 family
02

Mechanism of action

Facilitated diffusion or active transport of nucleosides and nucleobases; influences intracellular drug concentration and efficacy.

03

Biological functions

Nucleoside transportNucleobase transportNucleotide salvageDrug transportCellular metabolismSignaling (transceptor function)
04

Disease associations

CancerViral infectionsDrug resistanceMetabolic disorders
05

Safety considerations

Drug resistance developmentVariability in drug responseOff-target effects due to broad substrate specificityAltered nucleoside homeostasis
06

Interacting drugs

Gemcitabine

7 more in the full profile.

07

Biomarkers

ENT1 expression levelsCNT1 expression levelsCNT2 expression levelsCNT3 expression levelsPolymorphisms in SLC29A1 (ENT1)Polymorphisms in SLC28 genes (CNTs)

Beyond the preview

Go deeper on Nucleoside Transporter (NT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleoside Transporter (NT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call